Dr. Reddy’s shares hit record high! Pharma stock up 5% in 3 sessions
Shares of Dr. Reddy's Laboratories have risen 36% against its 52-week low of ₹5,212.10 touched on October 30, 2023.
Shares of Dr. Reddy's Laboratories have risen 36% against its 52-week low of ₹5,212.10 touched on October 30, 2023.
In the past one month, six months and one year, the counter has given 0.49%, 16.77% and 23.70% in returns, respectively.
The pharma major received “zero observations” post the USFDA pre-approval inspection (PAI) and a routine GMP inspection at the Andhra Pradesh facility
Dr. Reddy’s Laboratories has received the U.S. FDA approval to launch Fesoterodine Fumarate extended-release tablets in the American market